Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients
1996

Hepatocyte Growth Factor in Pleural Effusions from Cancer Patients

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): G Eagles, A Warn, RY Ball, H Baillie-Johnson, N Arakaki, Y Daikuhara, RM Warn

Primary Institution: School of Biology, University of East Anglia, Norwich NR4 7TJ, UK

Hypothesis

HGF/SF levels in pleural effusions from cancer patients may indicate tumor presence and activity.

Conclusion

Most pleural effusions from cancer patients contain significant levels of HGF/SF, suggesting its role in tumor growth and spread.

Supporting Evidence

  • Over 90% of pleural effusions from cancer patients contained detectable HGF/SF levels.
  • HGF/SF levels varied widely among different tumor types.
  • Median HGF/SF levels were highest in pleural mesotheliomas.

Takeaway

Doctors found a special protein called HGF/SF in the fluid around the lungs of many cancer patients, which might help tumors grow.

Methodology

Pleural effusion samples were collected from cancer patients and tested for HGF/SF using ELISA and bioassay methods.

Limitations

The study does not establish a direct causal relationship between HGF/SF levels and tumor behavior.

Participant Demographics

28 male and 27 female patients with a mean age of 66 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication